虚拟现实联合无创脑刺激改善卒中上肢运动功能的系统综述与荟萃分析
结果显示联合治疗组FMA-UE、MBI、WMFT评分显著提高,MAS评分显著降低,治疗时长影响日常生活活动结局。
要点
- VR联合NIBS可显著改善卒中患者上肢运动功能(FMA-UE SMD=0.85)。
- 联合治疗显著降低肌张力(MAS SMD=-0.51)并提高日常生活能力(MBI SMD=0.97)。
- 治疗时长是影响日常生活活动结局的关键因素。
核心结论
- VR与NIBS联合治疗对卒中患者上肢运动功能有显著改善作用,治疗时长对日常生活活动结局起关键作用。
研究设计与样本
- 系统综述与荟萃分析,注册于PROSPERO(CRD42023494220),遵循PRISMA指南。
- 纳入标准为接受VR联合NIBS治疗的卒中患者,排除文章或数据不完整的研究;采用Cochrane协作工具评估偏倚风险,使用Stata SE 15.0进行统计分析。
主要发现
- 共纳入11项研究、493例参与者。
- 联合治疗组FMA-UE评分较对照组显著提高(SMD=0.85,95%CI [0.40, 1.31],p=0.017)。
- MAS评分显著降低(SMD=-0.51,95%CI [-0.83, -0.20],p=0.032)。
- MBI评分显著提高(SMD=0.97,95%CI [0.76, 1.17],p=0.004)。
- WMFT评分显著提高(SMD=0.36,95%CI [0.08, 0.64],p=0.021);亚组分析提示治疗时长影响日常生活活动结局。
关键数值与推荐
- FMA-UE:SMD=0.85,95%CI [0.40, 1.31],p=0.017。
- MAS:SMD=-0.51,95%CI [-0.83, -0.20],p=0.032。
- MBI:SMD=0.97,95%CI [0.76, 1.17],p=0.004。
- WMFT:SMD=0.36,95%CI [0.08, 0.64],p=0.021。
临床怎么用
- 对卒中后上肢运动功能障碍患者,可考虑VR联合NIBS的康复方案以改善运动功能、降低肌张力并提高日常生活能力。
- 制定联合治疗方案时应重视治疗时长,以优化日常生活活动方面的获益。
局限性
- 存在语言偏倚。
- 随机化描述不清晰。
- 可能存在研究遗漏。
- 随访期不足。
- 未来研究应关注长期疗效并优化治疗时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke frequently results in upper limb motor dysfunction, with traditional therapies often failing to yield sufficient improvements. Emerging technologies such as virtual reality (VR) and noninvasive brain stimulation (NIBS) present promising new rehabilitation possibilities. OBJECTIVES: This study systematically reviews and meta-analyses the effectiveness of VR and NIBS in improving upper limb motor function in stroke patients. METHODS: Registered with PROSPERO (CRD42023494220) and adhering to the PRISMA guidelines, this study conducted a thorough search of databases including PubMed, MEDLINE, PEDro, REHABDATA, EMBASE, Web of Science, Cochrane, CNKI, Wanfang, and VIP from 2000 to December 1, 2023, to identify relevant studies. The inclusion criterion was stroke patients receiving combined VR and NIBS treatment, while exclusion criteria were studies with incomplete articles and data. The risk of bias was assessed using the Cochrane Collaboration tool. Statistical analysis was performed using Stata SE 15.0, employing either a fixed-effects model or a random-effects model based on the level of heterogeneity. RESULTS: A total of 11 studies involving 493 participants were included, showing a significant improvement in Fugl-Meyer Assessment Upper Extremity (FMA-UE) scores in the combined treatment group compared to the control group (SMD = 0.85, 95% CI [0.40, 1.31], p = 0.017). The Modified Ashworth Scale (MAS) scores significantly decreased (SMD = - 0.51, 95% CI [- 0.83, - 0.20], p = 0.032), the Modified Barthel Index (MBI) scores significantly increased (SMD = 0.97, 95% CI [0.76, 1.17], p = 0.004), and the Wolf Motor Function Test (WMFT) scores also significantly increased (SMD = 0.36, 95% CI [0.08, 0.64], p = 0.021). Subgroup analysis indicated that the duration of treatment influenced the outcomes in daily living activities. CONCLUSIONS: The combination of VR and NIBS demonstrates significant improvements in upper limb motor function in stroke patients. The duration of treatment plays a critical role in influencing the outcomes, particularly in activities of daily living. This systematic review has limitations, including language bias, unclear randomization descriptions, potential study omissions, and insufficient follow-up periods. Future studies should focus on exploring long-term effects and optimizing treatment duration to maximize the benefits of combined VR and NIBS therapy.
引用
- Zhang N, Wang H, Wang H, et al. Impact of the combination of virtual reality and noninvasive brain stimulation on the upper limb motor function of stroke patients: a systematic review and meta-analysis. J Neuroeng Rehabil. 2024. PMID: 39369259. doi:10.1186/s12984-024-01474-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。